Capture.Study vs Medidata Rave: A Faster Start for Smaller Trials
Medidata Rave is an enterprise EDC built for large, multinational pharma trials. Most teams comparing it to Capture.Study are looking for something that fits a smaller study and budget. Here is an honest look at both.
Who This Comparison Is For
Medidata Rave and Capture.Study serve very different points on the market. This page is useful if:
You are a small biotech or CRO
- Comparing Medidata against lighter options for a Phase I or II trial
- Want to avoid a multi-month enterprise implementation
- Need public pricing rather than a custom enterprise quote
You run large, multinational trials
- Medidata Rave is likely still the better fit today for global Phase III programs
- This page tells you honestly where that is true
Quick Comparison Table
| Feature | Capture.Study | Medidata Rave |
|---|---|---|
| Self-serve free sandbox, no sales call to start | Enterprise sales process | |
| Typical time to first build | Under 1 hour | Weeks of implementation |
| AI drafts CRFs from a protocol or description | Not a standard feature | |
| Built for global, multi-thousand-patient Phase III programs | Not the target use case | |
| ePRO, eConsent and randomization in one platform | Separate Medidata products | |
| Public, self-serve pricing | Custom enterprise pricing | |
| 21 CFR Part 11-aligned controls | ||
| Long track record in large pharma submissions | Newer platform |
We built this table from each vendor's own public positioning. If anything here is out of date, let us know.
Getting Started
Medidata Rave is sold through an enterprise sales process, with implementation typically measured in weeks and priced for large, well-funded programs. Capture.Study is self-serve: you can build and test your full study in a free sandbox today, with no credit card and no sales call, and only pay once you go live.
If your study is small to mid-size and budget or speed to first patient matters, that gap in getting started is usually the deciding factor.
Study Build
Rave Architect is a mature, powerful study-build tool used across thousands of pharma trials, typically operated by dedicated study-build teams or CRO partners. Capture.Study puts AI-assisted drafting and a visual builder directly in the hands of the study team, so you do not need a dedicated build specialist for a smaller protocol.
Scale
Medidata Rave is built and proven for large, multinational, multi-thousand-patient Phase III programs with complex site networks. Capture.Study targets a different point on the scale: early-phase, academic, and small-to-mid-size trials that do not need that level of enterprise infrastructure and do not want to pay for it. Neither platform is trying to be the other.
Compliance
Medidata has an extensive track record supporting FDA and global regulatory submissions across large pharma programs. Capture.Study provides 21 CFR Part 11-aligned controls today, a field-level audit trail that cannot be edited from the app, OTP-verified electronic signatures with countersignature, and role-based access, with documentation to support your own validation on Enterprise plans. If your program specifically requires Medidata's submission history and scale, that is a real, current advantage on their side.
Pricing
Medidata prices Rave through custom enterprise contracts scaled for large programs. Capture.Study includes a free sandbox for every study, with paid plans that scale with study size, visible without a sales conversation.
When Medidata Rave Is Still the Right Choice
Large, multinational Phase III programs
If you are running a multi-thousand-patient global trial with a dedicated study-build team, Medidata's scale and track record are hard to match.
You need Medidata's specific submission history
If a regulator relationship or internal SOP specifically references Medidata, switching adds risk without a clear upside.
When Capture.Study Is the Better Choice
You want to start without an enterprise sales cycle
Build and test your entire study in the free sandbox today. No procurement process required to see if it fits.
Your study does not need Rave's scale
Phase I/II, academic, and small-to-mid-size trials get the compliance controls they need without the enterprise overhead built for much larger programs.
You want your own team to build and amend forms
AI-assisted drafting and a visual builder mean your study team can build and adjust CRFs without a dedicated build specialist.
Frequently Asked Questions
Is Capture.Study a Medidata Rave alternative?
For small-to-mid-size and early-phase trials, yes. For large, multinational Phase III programs, Medidata Rave remains built for a scale Capture.Study does not target today.
Why is Medidata so much more expensive than Capture.Study?
Medidata prices Rave for large, complex, multi-site global programs with dedicated implementation and support. Capture.Study is built and priced for smaller studies that do not need that scale.
Can I try Capture.Study before deciding?
Yes. The free sandbox includes every feature with sample data, no credit card and no time limit, so you can test it against your own protocol.
Is Capture.Study 21 CFR Part 11-aligned like Medidata?
Yes. Capture.Study provides a field-level audit trail, OTP-verified electronic signatures with countersignature, and role-based access control, with documentation to support sponsor validation on Enterprise plans.
See If Capture.Study Fits Your Study
Free sandbox with no time limit. Build your study and test everything before paying a dollar.
No credit card required. No sales calls.